Bausch Health Companies Inc (NYSE:BHC)
$ 6.88 -0.07 (-1.01%) Market Cap: 2.53 Bil Enterprise Value: 23.88 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 73/100

Bausch Health Companies Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2020 / 07:50PM GMT
Release Date Price: $18.78 (-5.44%)
Terence Flynn

Good afternoon, everybody. I'm Terence Flynn, the biopharma analyst at Goldman Sachs. This afternoon, we're very pleased to host Bausch Health Companies. Today, joining us from the company, we have Joe Papa, Chairman and CEO; Joe Gordon, who is President and Co-Head of Bausch + Lomb International; Art Shannon, who's Senior Vice President and Head of Investor Relations and Global Communications. Thank you so much all for joining us today, really appreciate the time.

Joe, maybe I'll turn it over to you first to start with some opening remarks before we go through my questions.

Joseph C. Papa
Bausch Health Companies Inc. - Chairman & CEO

Sure. It's a pleasure to have a chance to talk to everybody today. We've been undergoing a transformation of Bausch Health over the past 4 years, and we put together a brand-new team, brand-new leadership team, and we've made great progress. We've now reported 9 consecutive quarters of organic growth. We've got a really strong eye health business with our Bausch + Lomb business, driven by mega trends, which

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot